(WASHINGTON, November 7, 2019) – The American Society of
Hematology (ASH) is pleased to recognize the following trainees, whose
meritorious scientific abstract has received one of the awards in the
ASH Abstract
Achievement Award program portfolio
, at the 61st ASH Annual Meeting,
December 7-10 in Orlando.
Trainees and trainee led research are vital to the advancement of the field of hematology. ASH, recognizing the impact of research conducted by the next generation of leaders in the field, has a comprehensive award program dedicated to recognizing commendable science submitted to the ASH Annual Meeting.
“I am thrilled to acknowledge these talented early-career researchers for their outstanding contributions in hematology,” said ASH President Roy Silverstein, MD, of the Medical College of Wisconsin in Milwaukee. “Being able to present their work at the annual meeting is an incredible opportunity for them to gain recognition for their hard work and grow in their careers.”
The 2019 Outstanding Abstract Achievement Award
recipients are:
Undergraduate Student
Stacy B. Kiven, BS
University of Minnesota, Minneapolis, MN
Abstract
76
Calpain-1 Contributes to Pain and
Organ Damage in Sickle Cell Disease
Medical Student
Hrishikesh Srinagesh, BA
Icahn School of Medicine at Mount Sinai, New York, NY
Abstract
367
The MAGIC Algorithm Probability
(MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute
Graft-Versus-Host Disease
Graduate Student
Melanie Castro-Mollo, MD
Icahn School of Medicine at Mount Sinai, New York, NY
Abstract
2
Erythroferrone Regulates Bone
Remodeling in β-Thalassemia
Resident Physician
Naranie Shanmuganathan, MBBS, FRACP, FRCPA
Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
Abstract
662
RNA Splicing Defects in
Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated
with TKI Resistance in CML
Post-Doctoral Fellow
Tomoya Muto, MD PhD
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Abstract
727
Innate Immune Signaling Suppresses
Acute Leukemia By Modifying MYC Oncogenic Activity
Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis
The Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis was
established to recognize the trainee (undergraduate student, medical student,
graduate student, resident physician, or post-doctoral fellow) who is the first
author and presenter of the highest-scoring abstract submitted to the ASH
Annual Meeting in the field of hemostasis and thrombosis. This annual award
honoring excellence in hemostasis and thrombosis is made possible by the Mary
Rodes Gibson Hemostasis-Thrombosis Foundation to continue the legacy of Mary
Rodes Gibson, who suffered from severe, type 3 von Willebrand disease.
This award will be presented during the invited speaker session of the Special Symposium on the Basic Science of Hemostasis and Thrombosis on Monday, December 9, 2019 from 4:30 PM – 6:30 PM, OCCC, Tangerine 3 (WF3-4).
The 2019 recipient is:
Oluwatoyosi Muse, PhD
Beth Israel Deaconess Medical Center, Boston, MA
Abstract
632
The Unfolded Protein Response Causes Prothrombotic Transformation of
Pancreatic Cancer Linking Tumor Progression with Cancer-Associated Thrombosis
2019 recipients are:
Hassan Awada, MD
Cleveland Clinic, Cleveland, Ohio
Abstract
2499
Molecular Characterization of Leukemia Evolving from Paroxysmal Nocturnal Hemoglobinuria
Tanabe Mikoto, MD
Kanazawa University, Kanazawa, Japan
Abstract
3736
A GPI-Anchored Protein, CD109, Protects Hematopoietic Progenitor Cells
from Erythroid Differentiation Induced By TGF-β.
Giuseppe Bigi Memorial Award
The ASH Giuseppe Bigi Memorial Award was established in 2015 to recognize an
Italian trainee (undergraduate student, medical student, graduate student,
resident physician, or post-doctoral fellow) based at an Italian institution
who has the highest-scoring abstract submitted in the field of hematopoiesis
and stem cells. This annual award is made possible by a generous grant from the Giuseppe Bigi Association, named for the late Giuseppe Bigi, MD, a well-known Italian scientist.
The 2019 recipient is:
Marilena Ciciarello, PhD
Azienda Ospedaliero-Universitaria S. Orsola- Malphighi, Bologna, Italy
Abstract
1212
Interferon-γ-Dependent Inflammatory Signature in Acute Myeloid
Leukemia Cells Is Able to Shape Stromal and Immune Bone Marrow Microenvironment
Giuseppe Bigi Abstract Achievement Award Recipient
The 2019 recipient is:
Annamaria April, PhD-IRCCS
San Raffaelle Scientific Institute, Milano, Italy
Abstract
967
Hematopoietic Stem Cell Function in β-Thalassemia Is Impaired and Is Rescued By Targeting the Bone Marrow Niche
ASH-British
Society of Haematology Abstract Achievement Award
2019 recipients are:
Sam Alimam, DHCS, MD
King’s College London, London, United Kingdom
Abstract
308
Molecular, Epigenetic and Gene Expression Profiling of Triple Negative
Essential Thrombocythaemia
Claire Burney, MBBS
University Hospitals Bristol, Bristol, United Kingdom
Abstract
701
Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line
Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 – a
Retrospective Study from the LWP-EBMT
Konstantinos Tzelepis, PhD
University of Cambridge, Cambridge, United Kingdom
Abstract
403
Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel
Therapeutic Strategy for Acute Myeloid Leukemia
ASH-Haematology Society of Australia and New Zealand Abstract Achievement Award
2019 recipient is:
Chong Chyn Chua, MBBS, FRACP, FRCPA
The Alfred Hospital and Monash University, Melbourne, Australia
Abstract
462
Anti-Leukemic Activity of Single Agent Venetoclax in Newly Diagnosed Acute
Myeloid Leukemia: A Sub-Set Analysis of the Caveat Study.
ASH-Japanese Society of Hematology Abstract Achievement Award
2019 recipients are:
Takeshi Fujino, MD
University of Tokyo, Tokyo, Japan
Abstract
821
Mutant ASXL1 Promotes Expansion of the Phenotypic Hematopoietic Stem Cell
Compartment
Haruko Shima, MD, PhD
Keio University School of Medicine, Tokyo, Japan
Abstract
25
Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic
Myeloid Leukemia (JPLSG STKI-14 study)
Koya Ono, MD
Tohoku University Graduate School of Medicine, Sendai, Japan
Abstract
3530
Molecular Characterization and Novel Therapeutic Strategy for X-Linked Siderblastic Anemia Associated with ALAS2 Missense Variants
ASH-Society Italiana di Ematologia Abstract Achievement Award
2019 recipients are:
Chiara Magnani, PhD
University of Milano-Bicocca/Fondazione MBBM, Milano, Italy
Abstract
200
Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered
with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic
Leukemia (B-ALL)
Pier Edoardo Rovatti, MD
IRCCS San Raffaele Scientific Institute, Milano, Italy
Abstract
513
Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T
Cells Against HLA Loss Leukemia Relapses
Minority Graduate Student Abstract Achievement Award
Each year, ASH offers merit-based Minority Graduate Student Abstract
Achievement Awards to select graduate students to honor their research accomplishments and to recruit and retain underrepresented minority graduate students in the field of hematology through exposure to the ASH Annual Meeting.
The 2019 Minority Graduate Student Abstract Achievement Award recipients are:
Adedamola Elujoba-Bridenstine, MS
University of Illinois at Chicago, Chicago, Illinois
Abstract
3707
The Neurotransmitter Receptor Gabbr1 Regulates Proliferation and Function of Hematopoietic Stem and Progenitor Cells
Marcus Florez, BS
Baylor College of Medicine, Houston, TX
Abstract
3726
IFNy Stimulation Induces Hematopoietic Stem Cell Homing and Niche Relocalization
Mohammed Gbadamosi, BS
University of Florida College of Pharmacy, Gainesville, FL
Abstract
908
Novel CD33 Antibodies Unravel Localization, Biology, and Therapeutic
Implications of CD33 Isoforms
Jamie Hamilton, BS
Emory University, Atlanta, GA
Abstract
1468
Elevated Levels of Interleukin-9 in Obese Microenvironments Promote
Leukemia Progression and Chemoresistance in B-Cell Acute Lymphoblastic Leukemia
Cells
Joseph Krambs, BS
Washington University School of Medicine, St. Louis, MO
Abstract
1209
Canonical Signaling By TGF Family Members in Mesenchymal Stromal
Cells Is Dispensable for Hematopoietic Niche Maintenance Under Basal and Stress
Conditions
Emaan Madany, BS
Cedars-Sinai Medical Center, Los Angeles, CA
Abstract
716
Increased Expression of Type 1 Interferon Stimulated Genes in Sickle
Cell Disease and a Potential Association with RBC Alloimmunization
###
A complete list of Abstract Achievement Award recipients will
be available at
https:/
/
www.
hematology.
org/
Awards/
Award-Recipients/
Abstract-Achievement/
The American Society of Hematology (ASH) (
http://www.
hematology.
org
) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes
Blood
(
http://www.
bloodjournal.
org
), the most cited peer-reviewed publication in the field, and
Blood Advances
(
http://www.
bloodadvances.
org
), an online, peer-reviewed open-access
journal.
Contact:
Sara Khalaf, American Society of Hematology
[email protected]
“>
[email protected]
;
202-552-4925
This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-11/asoh-aat110719.php
Sara Khalaf
202-552-4925
[email protected]
http://www.hematology.org